NCT06916169View on ClinicalTrials.gov

A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Pharmacokinetics
Interventions
DRUG

AG2304

AG2304, Single-dose Oral Administration

DRUG

AG23041 and AG23042

AG23041/AG23042, Single-dose Oral Administration

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT06916169 - A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 | Biotech Hunter | Biotech Hunter